Inlif Limited closes $3.75M registered direct offering on Nasdaq

Inlif Limited (Nasdaq: INLF), a China-based manufacturer of injection molding machine manipulator arms, announced the closing of a registered direct offering that raised approximately $3.75 million in gross proceeds, before deducting placement agent fees and other expenses.

The company issued 435,000 Class A Ordinary Shares at a combined purchase price of $1.60 per share, along with pre-funded warrants to purchase up to 1,908,750 shares at $1.5999 per unit. The offering also included three series of warrants: Series A warrants exercisable at $1.60 per share for five years, Series B warrants exercisable at $1.60 per unit and expiring 60 days after issuance, and Series C warrants exercisable at $0.0001 per share with terms based on a price adjustment over the first ten trading days after issuance. Both Series A and Series B warrants are subject to a one-time downward exercise price reset on the twentieth trading day after closing.

Inlif said it plans to use the net proceeds for working capital and capital expenditures over the next one to two years, including a Phase II manufacturing facility, production and research and development equipment, its Xiamen headquarters, new product development including industrial robots, and talent recruitment.

Maxim Group LLC served as the sole placement agent. Ortoli Rosenstadt LLP acted as U.S. securities counsel to the company, and Pryor Cashman LLP acted as U.S. securities counsel to the placement agent.

The offering was conducted under a shelf registration statement on Form F-3 filed with the U.S. Securities and Exchange Commission on January 5, 2026, and declared effective on January 12, 2026.

You May Also Be Interested In

• Evommune raises $30M in private placement at $6.04 per share
• Parabolic Technologies prices $13.5M public offering on Nasdaq
• AMTD IDEA in talks to acquire third New York City hotel